文献库，生知库 | 链接生命科学的每一步

日期影响因子

Development of the First Low Nanomolar Liver Receptor Homolog-1 Agonist through Structure-guided Design.

通过结构导向设计开发首个低纳摩尔肝受体同源物-1激动剂

期刊:Journal of Medicinal Chemistry

影响因子:6.8

doi:10.1021/acs.jmedchem.9b00753

Mays Suzanne G, Flynn Autumn R, Cornelison Jeffery L, Okafor C Denise, Wang Hongtao, Wang Guohui, Huang Xiangsheng, Donaldson Heather N, Millings Elizabeth J, Polavarapu Rohini, Moore David D, Calvert John W, Jui Nathan T, Ortlund Eric A

发表日期：2019

文献求助收藏

Everolimus-eluting stents improve vascular response in a diabetic animal model

依维莫司洗脱支架可改善糖尿病动物模型中的血管反应

期刊:Circulation-Cardiovascular Interventions

影响因子:7.4

doi:10.1161/CIRCINTERVENTIONS.113.001023

Habib, Anwer; Karmali, Vinit; John, Michael C; Polavarapu, Rohini; Nakazawa, Gaku; Pachura, Kim; Davis, Talina; Kolodgie, Frank D; Virmani, Renu; Finn, Aloke V

发表日期：2014

文献求助收藏

Sirolimus-FKBP12.6 impairs endothelial barrier function through protein kinase C-α activation and disruption of the p120-vascular endothelial cadherin interaction

Sirolimus-FKBP12.6 通过激活蛋白激酶 C-α 和破坏 p120-血管内皮钙黏蛋白相互作用来损害内皮屏障功能。

期刊:Arteriosclerosis Thrombosis and Vascular Biology

影响因子:7.4

doi:10.1161/ATVBAHA.113.301659

Habib, Anwer; Karmali, Vinit; Polavarapu, Rohini; Akahori, Hirokuni; Cheng, Qi; Pachura, Kim; Kolodgie, Frank D; Finn, Aloke V

发表日期：2013

文献求助收藏

Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis

药物抑制铁调素可增加巨噬细胞胆固醇外流，并减少泡沫细胞形成和动脉粥样硬化。

期刊:Arteriosclerosis Thrombosis and Vascular Biology

影响因子:7.4

doi:10.1161/ATVBAHA.111.240101

Saeed, Omar; Otsuka, Fumiyuki; Polavarapu, Rohini; Karmali, Vinit; Weiss, Daiana; Davis, Talina; Rostad, Brad; Pachura, Kimberly; Adams, Lila; Elliott, John; Taylor, W Robert; Narula, Jagat; Kolodgie, Frank; Virmani, Renu; Hong, Charles C; Finn, Aloke V

细胞生物学

动脉粥样硬化

免疫/内分泌

发表日期：2012

文献求助收藏